Clinical Trial

Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group

Study acronym: POGASH
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Multicentric registry study in order to define outcome, predictors, treatment effects and their modifiers in poor grade aneurysmal subarachnoid haemorrhage patients. The search for outcome predictors is going to be subdivided into three main research areas: 1. outcome predictors in the emergency department (so called "early brain injury phase"). 2. outcome predictors in the neurocritical care unit (so called "delayed brain injury phase"). 3. Treatment strategies. Two other areas of research are identified: delayed cerebral ischemia (incidence, treatment, predictors, impact on outcome) and long term follow-up (recent evidences suggest that there may be a non-negligible proportion of poor grade subarachnoid hemorrhage patients who may benefit from substantial improvement at long-term (after 6-12 months of follow-up).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-06-22; most recent amendment 2023-11-24.
Trial Details
NCT Number NCT04945603
Lead Sponsor IRCCS San Raffaele
Collaborators: Azienda Ospedaliera Universitaria Integrata Verona, Azienda Ospedaliero-Universitaria di Parma, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, A.O. Ospedale Papa Giovanni XXIII, ASL Taranto, Ospedale V. Fazzi, IRCCS Istituto delle Scienze Neurologiche di Bologna, Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions Subarachnoid Hemorrhage, Aneurysmal, Poor Grade Subarachnoid Hemorrhage
Enrollment 800 participants
Start Date 2021-05-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-11-29